NeoGenomics
NEO
287 hedge funds and large institutions have $2.07B invested in NeoGenomics in 2023 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 89 increasing their positions, 96 reducing their positions, and 35 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
171% more call options, than puts
Call options by funds: $17.6M | Put options by funds: $6.48M
40% more capital invested
Capital invested by funds: $1.48B → $2.07B (+$587M)
17% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 35
5.86% more ownership
Funds ownership: 94.35% → 100.21% (+5.9%)
1% more funds holding
Funds holding: 284 → 287 (+3)
7% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 96
Top Buyers
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$32.1M |
| 2 |
Morgan Stanley
New York
|
+$31.6M |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
+$22.9M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$17.4M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$14.7M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$13.5M |
| 2 |
D.E. Shaw & Co
New York
|
-$6.26M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.51M |
| 4 |
JP Morgan Chase
New York
|
-$5.15M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.55M |
NEO Hedge Fund Activity: Q4 2023 in Review
287 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q4 2023, worth a combined $2.07B — up 40% from $1.48B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new NEO positions and 35 closed out — a net gain of 6 holders — while 89 added to existing stakes and 96 trimmed.
The largest buyer was American Century Companies, adding an estimated $32.1M. The largest seller was Janus Henderson Group, cutting an estimated $13.5M.
- 287 institutional investors held NeoGenomics (NEO) as of Q4 2023, up from 284 in Q3 2023.
- Funds reported $2.07B of NeoGenomics stock for Q4 2023, up 40% quarter-over-quarter.
- 41 funds opened new NeoGenomics positions in Q4 2023 and 35 closed out, a net change of +6 holders.
- The largest NeoGenomics buyer in Q4 2023 was American Century Companies, an estimated $32.1M added.
- The largest NeoGenomics seller in Q4 2023 was Janus Henderson Group, an estimated $13.5M sold.
Based on aggregated 13F filings for Q4 2023.